BlackRock Sus Adg Intl Eq Inv A BRZAX

Medalist Rating as of | See BlackRock Investment Hub
  • NAV / 1-Day Return 12.12  /  +0.58 %
  • Total Assets 17.4 Mil
  • Adj. Expense Ratio
    0.750%
  • Expense Ratio 0.750%
  • Distribution Fee Level Low
  • Share Class Type Front Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 2.22%
  • Turnover 89%

USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:28 PM GMT+0

Morningstar’s Analysis BRZAX

Will BRZAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin BlackRock Sus Adg Intl Eq Inv A's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BRZAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 20.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk AS Class B

3.29 579,543
Healthcare

ASML Holding NV

2.59 456,592
Technology

BlackRock Liquidity T-Fund Instl

2.11 371,652
Cash and Equivalents

Novartis AG Registered Shares

2.06 363,610
Healthcare

AstraZeneca PLC

2.05 360,944
Healthcare

SAP SE

2.01 353,891
Technology

Shell PLC

1.99 350,342
Energy

Nestle SA

1.65 290,401
Consumer Defensive

Siemens AG

1.54 271,594
Industrials

Schneider Electric SE

1.53 270,527
Industrials

Sponsor Center